Finding which patients benefit most from alcohol use disorder medications
Identifying patient subgroups that are most likely to benefit from medications used to treat alcohol use disorder
This study is looking to find out which groups of people with alcohol use disorder are most likely to get better with certain medications, so that doctors can give the best treatment tailored to each person's needs.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11023129 on NIH RePORTER |
What this research studies
This research aims to identify specific patient groups that are most likely to benefit from medications used to treat alcohol use disorder (AUD). The approach involves analyzing existing data from large clinical trials to determine which characteristics of patients correlate with successful treatment outcomes. By synthesizing and evaluating evidence from multiple sources, the research seeks to improve clinical decision-making and ensure that patients receive the most effective treatments available for AUD. This could lead to more personalized and effective care for individuals struggling with alcohol use.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with alcohol use disorder who are seeking treatment.
Not a fit: Patients who do not have alcohol use disorder or those who are not seeking medication treatment for their condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more targeted and effective medication treatments for individuals with alcohol use disorder.
How similar studies have performed: Previous research has shown promise in identifying patient subgroups for various treatments, suggesting that this approach could yield valuable insights for alcohol use disorder as well.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Wallach, Joshua David — Emory University
- Study coordinator: Wallach, Joshua David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.